Company intelligence / Profile preview

ChemFarm

Daejeon, South Korea

Ownership: Private
Development stage: Other

Overview

ChemFarm is a South Korean biotechnology company specializing in the discovery and development of innovative small molecule therapeutics. The company utilizes its proprietary drug discovery platform to identify novel targets and optimize lead compounds across various therapeutic areas, including oncology, metabolic diseases, and fibrosis. ChemFarm aims to bridge the gap between early-stage research and clinical development through strategic partnerships and internal R&D efforts. Its lead programs include CF-101, a potential treatment for non-alcoholic steatohepatitis (NASH), and several oncology candidates targeting solid tumors. The company is headquartered in the biotech hub of Daejeon and is supported by prominent Korean venture capital firms.

Therapeutic areas: OncologyOtherGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on ChemFarm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemFarm.

Explore the full profile